Skip to navigation Skip to main content

Belinostat (Beleodaq)

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews belinostat (Beleodaq), indicated for relapsed or refractory peripheral T-cell lymphoma (PTCL).

Table of Contents

Slide 4: Dosage and Administration
Slide 12: Cautions, Effects, and Interactions
Slide 18: What to Tell Your Patient
Slide 24: Reference 

Topics:

Drug Information Slideshows Stat Consult
  • Loading...

    Continuing Medical Education (CME/CE) Courses

    Show More

Next hm-slideshow in Slides